Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 229-240 of 6,115
Drug study icon
Enrolling By InvitationNCT07161700

Safety study of SPT-300 (GlyphAllo) in depression

This study is enrolling by invitation in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.

Multiple locations, including Chino
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 66 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Seaport Therapeutics
Condition
Depression
Drug study icon
Enrolling By InvitationNCT06580041

Precision Care for Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Depression
Other study type icon
Enrolling By InvitationNCT07345858

Salivary Oxytocin as a Biomarker of Psychedelic Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In Geneva
Why is this study shown?

This study is directly about Depression.

DepressionObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Switzerland
Sponsor
University of Geneva, Switzerland
Condition
Depression
Drug study icon
Not recruitingEUCTR 2022-000430-42

An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Alken
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
France, Belgium, Bulgaria, ...
Sponsor
Janssen-Cilag International NV
Condition
Depression
Behavioral study icon
RecruitingNCT05388461

Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bergen
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
Norway
Sponsor
Haukeland University Hospital
Condition
Depression
Behavioral study icon
RecruitingNCT06748209

Establishing Mobile Transcranial Magnetic Stimulation

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 22 Years to 80 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Depression
Drug study icon
RecruitingNCT02122562

Ketamine Alcohol (in Treatment-Resistant Depression)

This summary needs review. Please check the official study record and contact the research team for details.

In Iowa City
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Mark Niciu
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.